{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T23:26:29Z","timestamp":1783380389295,"version":"3.54.6"},"reference-count":79,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,7,13]],"date-time":"2022-07-13T00:00:00Z","timestamp":1657670400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,7,13]],"date-time":"2022-07-13T00:00:00Z","timestamp":1657670400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Zewail City of Science & Technology"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>COVID-19 is a global pandemic impacting the daily living of millions. As variants of the virus evolve, a complete comprehension of the disease and drug targets becomes a decisive duty. The Omicron variant, for example, has a notably high transmission rate verified in 155 countries. We performed integrative transcriptomic and network analyses to identify drug targets and diagnostic biomarkers and repurpose FDA-approved drugs for SARS-CoV-2. Upon the enrichment of 464 differentially expressed genes, pathways regulating the host cell cycle were significant. Regulatory and interaction networks featured hsa-mir-93-5p and hsa-mir-17-5p as blood biomarkers while hsa-mir-15b-5p as an antiviral agent. MYB, RRM2, ERG, CENPF, CIT, and TOP2A are potential drug targets for treatment. HMOX1 is suggested as a prognostic biomarker. Enhancing HMOX1 expression by neem plant extract might be a therapeutic alternative. We constructed a drug-gene network for FDA-approved drugs to be repurposed against the infection. The key drugs retrieved were members of anthracyclines, mitotic inhibitors, anti-tumor antibiotics, and CDK1 inhibitors. Additionally, hydroxyquinone and digitoxin are potent TOP2A inhibitors. Hydroxyurea, cytarabine, gemcitabine, sotalol, and amiodarone can also be redirected against COVID-19. The analysis enforced the repositioning of fluorouracil and doxorubicin, especially that they have multiple drug targets, hence less probability of resistance.<\/jats:p>","DOI":"10.1038\/s41598-022-15898-w","type":"journal-article","created":{"date-parts":[[2022,7,13]],"date-time":"2022-07-13T16:05:02Z","timestamp":1657728302000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["SARS-CoV-2 potential drugs, drug targets, and biomarkers: a viral-host interaction network-based analysis"],"prefix":"10.1038","volume":"12","author":[{"given":"Asmaa","family":"Samy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed A.","family":"Maher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nehal Adel","family":"Abdelsalam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9531-2266","authenticated-orcid":false,"given":"Eman","family":"Badr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,7,13]]},"reference":[{"key":"15898_CR1","unstructured":"Organization, W.\u00a0H. Who coronavirus (COVID-19) dashboard. https:\/\/covid19.who.int\/ (2022)."},{"key":"15898_CR2","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.ijid.2020.01.009","volume":"91","author":"DS Hui","year":"2020","unstructured":"Hui, D. S. et al. The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health - The latest 2019 novel coronavirus outbreak in Wuhan, China. Int. J. Infect. Dis. 91, 264\u2013266 (2020).","journal-title":"Int. J. Infect. Dis."},{"key":"15898_CR3","unstructured":"Zhou, P. et\u00a0al. Discovery of a novel coronavirus associated with the recent pneumonia outbreak in humans and its potential bat origin. BioRxiv (2020)."},{"key":"15898_CR4","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1038\/s41564-020-0695-z","volume":"5","author":"AE Gorbalenya","year":"2020","unstructured":"Gorbalenya, A. E. et al. The species Severe acute respiratory syndrome-related coronavirus: Classifying 2019-nCoV and naming it SARS-CoV-2. Nat. Microbiol. 5, 536 (2020).","journal-title":"Nat. Microbiol."},{"key":"15898_CR5","unstructured":"Organization, W.\u00a0H. Who director-general\u2019s opening remarks at the media briefing on COVID-19-11 march 2020. https:\/\/www.who.int\/director-general\/speeches\/detail\/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---11-march-2020 (2020)."},{"key":"15898_CR6","unstructured":"Organization, W.\u00a0H. Update on omicron. https:\/\/www.who.int\/news\/item\/28-11-2021-update-on-omicron (2021)."},{"key":"15898_CR7","unstructured":"CDC, C. D.\u00a0T. Global variants report. https:\/\/covid.cdc.gov\/covid-data-tracker\/#global-variant-report-map (2022)."},{"key":"15898_CR8","doi-asserted-by":"crossref","unstructured":"Mason, R.\u00a0J. Pathogenesis of COVID-19 from a cell biology perspective (2020).","DOI":"10.1183\/13993003.00607-2020"},{"key":"15898_CR9","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1001\/jama.2020.2648","volume":"323","author":"Z Wu","year":"2020","unstructured":"Wu, Z. & McGoogan, J. M. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: Summary of a report of 72 314 cases from the Chinese center for disease control and prevention. Jama 323, 1239\u20131242 (2020).","journal-title":"Jama"},{"key":"15898_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1743-422X-2-66","volume":"2","author":"X Yuan","year":"2005","unstructured":"Yuan, X., Shan, Y., Zhao, Z., Chen, J. & Cong, Y. G0\/G1 arrest and apoptosis induced by SARS-CoV 3b protein in transfected cells. Virol. J. 2, 1\u20135 (2005).","journal-title":"Virol. J."},{"key":"15898_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.virusres.2018.05.019","volume":"253","author":"P Sun","year":"2018","unstructured":"Sun, P. et al. Porcine epidemic diarrhea virus through P53-dependent pathway causes cell cycle arrest in the g0\/g1 phase. Virus Res. 253, 1\u201311 (2018).","journal-title":"Virus Res."},{"key":"15898_CR12","doi-asserted-by":"publisher","first-page":"5658","DOI":"10.1128\/JVI.78.11.5658-5669.2004","volume":"78","author":"C-J Chen","year":"2004","unstructured":"Chen, C.-J. & Makino, S. Murine coronavirus replication induces cell cycle arrest in G0\/G1 phase. J. Virol. 78, 5658\u20135669 (2004).","journal-title":"J. Virol."},{"key":"15898_CR13","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/j.virol.2007.04.015","volume":"365","author":"FQ Li","year":"2007","unstructured":"Li, F. Q., Tam, J. P. & Liu, D. X. Cell cycle arrest and apoptosis induced by the coronavirus infectious bronchitis virus in the absence of p53. Virology 365, 435\u2013445 (2007).","journal-title":"Virology"},{"key":"15898_CR14","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.virusres.2013.09.036","volume":"178","author":"L Ding","year":"2013","unstructured":"Ding, L. et al. Transmissible gastroenteritis virus infection induces cell cycle arrest at S and G2\/M phases via P53-dependent pathway. Virus Res. 178, 241\u2013251 (2013).","journal-title":"Virus Res."},{"key":"15898_CR15","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1080\/15384101.2020.1867792","volume":"20","author":"F Abedi","year":"2021","unstructured":"Abedi, F., Rezaee, R., Hayes, A. W., Nasiripour, S. & Karimi, G. MicroRNAs and SARS-CoV-2 life cycle, pathogenesis, and mutations: Biomarkers or therapeutic agents?. Cell Cycle 20, 143\u2013153 (2021).","journal-title":"Cell Cycle"},{"key":"15898_CR16","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1146\/annurev.cellbio.23.090506.123406","volume":"23","author":"N Bushati","year":"2007","unstructured":"Bushati, N. & Cohen, S. M. microRNA functions. Annu. Rev. Cell Dev. Biol. 23, 175\u2013205 (2007).","journal-title":"Annu. Rev. Cell Dev. Biol."},{"key":"15898_CR17","doi-asserted-by":"publisher","first-page":"440","DOI":"10.3390\/v10080440","volume":"10","author":"A Bernier","year":"2018","unstructured":"Bernier, A. & Sagan, S. M. The diverse roles of microRNAs at the host-virus interface. Viruses 10, 440 (2018).","journal-title":"Viruses"},{"key":"15898_CR18","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0235987","volume":"15","author":"S Nersisyan","year":"2020","unstructured":"Nersisyan, S., Shkurnikov, M., Turchinovich, A., Knyazev, E. & Tonevitsky, A. Integrative analysis of miRNA and mRNA sequencing data reveals potential regulatory mechanisms of ACE2 and TMPRSS2. PLoS One 15, e0235987 (2020).","journal-title":"PLoS One"},{"key":"15898_CR19","doi-asserted-by":"publisher","first-page":"462","DOI":"10.3390\/biomedicines8110462","volume":"8","author":"A Matarese","year":"2020","unstructured":"Matarese, A., Gambardella, J., Sardu, C. & Santulli, G. miR-98 regulates TMPRSS2 expression in human endothelial cells: Key implications for COVID-19. Biomedicines 8, 462 (2020).","journal-title":"Biomedicines"},{"key":"15898_CR20","doi-asserted-by":"publisher","first-page":"765","DOI":"10.3389\/fgene.2020.00765","volume":"11","author":"M Khan","year":"2020","unstructured":"Khan, M. et al. Epigenetic regulator miRNA pattern differences among SARS-CoV, SARS-CoV-2, and SARS-CoV-2 world-wide isolates delineated the mystery behind the epic pathogenicity and distinct clinical characteristics of pandemic COVID-19. Front. Genet. 11, 765 (2020).","journal-title":"Front. Genet."},{"key":"15898_CR21","doi-asserted-by":"publisher","first-page":"509","DOI":"10.14336\/AD.2020.0428","volume":"11","author":"S Fulzele","year":"2020","unstructured":"Fulzele, S. et al. COVID-19 virulence in aged patients might be impacted by the host cellular MicroRNAs abundance\/profile. Aging Dis. 11, 509 (2020).","journal-title":"Aging Dis."},{"key":"15898_CR22","doi-asserted-by":"crossref","unstructured":"Bagga, S. & Bouchard, M.\u00a0J. Cell cycle regulation during viral infection. Cell Cycle Control 165\u2013227 (2014).","DOI":"10.1007\/978-1-4939-0888-2_10"},{"key":"15898_CR23","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/nrd.2018.168","volume":"18","author":"S Pushpakom","year":"2019","unstructured":"Pushpakom, S. et al. Drug repurposing: Progress, challenges and recommendations. Nat. Rev. Drug Discov. 18, 41\u201358 (2019).","journal-title":"Nat. Rev. Drug Discov."},{"key":"15898_CR24","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1038\/s41586-020-2286-9","volume":"583","author":"DE Gordon","year":"2020","unstructured":"Gordon, D. E. et al. A SARS-CoV-2 protein interaction map reveals targets for drug repurposing. Nature 583, 459\u2013468 (2020).","journal-title":"Nature"},{"key":"15898_CR25","doi-asserted-by":"crossref","unstructured":"Suryawanshi, R.\u00a0K., Koganti, R., Agelidis, A., Patil, C.\u00a0D. & Shukla, D. Dysregulation of Cell Signaling by SARS-CoV-2. Trends Microbiol. (2020).","DOI":"10.1016\/j.tim.2020.12.007"},{"key":"15898_CR26","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1158\/2159-8290.CD-20-0559","volume":"10","author":"B Tutuncuoglu","year":"2020","unstructured":"Tutuncuoglu, B. et al. The landscape of human cancer proteins targeted by SARS-CoV-2. Cancer Discov. 10, 916\u2013921 (2020).","journal-title":"Cancer Discov."},{"key":"15898_CR27","doi-asserted-by":"publisher","first-page":"943","DOI":"10.3389\/fvets.2020.586826","volume":"7","author":"M Su","year":"2020","unstructured":"Su, M. et al. A mini-review on cell cycle regulation of coronavirus infection. Front. Vet. Sci. 7, 943 (2020).","journal-title":"Front. Vet. Sci."},{"key":"15898_CR28","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/j.cell.2020.06.034","volume":"182","author":"M Bouhaddou","year":"2020","unstructured":"Bouhaddou, M. et al. The global phosphorylation landscape of SARS-CoV-2 infection. Cell 182, 685\u2013712 (2020).","journal-title":"Cell"},{"key":"15898_CR29","doi-asserted-by":"crossref","unstructured":"Gao, X. et\u00a0al. Genome-wide screening of SARS-CoV-2 infection-related genes based on the blood leucocytes sequencing dataset of patients with COVID-19. J. Med. Virol. (2021).","DOI":"10.1002\/jmv.27093"},{"key":"15898_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.imu.2021.100702","volume":"25","author":"M Shahjaman","year":"2021","unstructured":"Shahjaman, M., Rahman, M. R. & Auwul, M. R. A network-based systems biology approach for identification of shared gene signatures between male and female in COVID-19 datasets. Inform. Med. Unlocked 25, 100702 (2021).","journal-title":"Inform. Med. Unlocked"},{"key":"15898_CR31","doi-asserted-by":"crossref","unstructured":"Mo, S. et\u00a0al. Comprehensive analysis of the systemic transcriptomic alternations and inflammatory response during the occurrence and progress of COVID-19. Oxid. Med. Cell. Longev. 2021 (2021).","DOI":"10.1155\/2021\/9998697"},{"key":"15898_CR32","doi-asserted-by":"crossref","unstructured":"V\u00e1zquez-Jim\u00e9nez, A. et\u00a0al. On deep landscape exploration of COVID-19 patients cells and severity markers. Front. Immunol. 12 (2021).","DOI":"10.3389\/fimmu.2021.705646"},{"key":"15898_CR33","doi-asserted-by":"crossref","unstructured":"Chen, J.-C. et\u00a0al. Identification of key pathways and genes in SARS-CoV-2 infecting human intestines by bioinformatics analysis. Biochem. Genet. 1\u201319 (2021).","DOI":"10.1007\/s10528-021-10144-w"},{"key":"15898_CR34","doi-asserted-by":"publisher","first-page":"402","DOI":"10.3389\/fendo.2018.00402","volume":"9","author":"J O\u2019Brien","year":"2018","unstructured":"O\u2019Brien, J., Hayder, H., Zayed, Y. & Peng, C. Overview of MicroRNA biogenesis, mechanisms of actions, and circulation. Front. Endocrinol. 9, 402 (2018).","journal-title":"Front. Endocrinol."},{"key":"15898_CR35","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0265670","volume":"17","author":"RJ Farr","year":"2022","unstructured":"Farr, R. J. et al. Detection of sars-cov-2 infection by microrna profiling of the upper respiratory tract. Plos ONE 17, e0265670 (2022).","journal-title":"Plos ONE"},{"key":"15898_CR36","volume":"10","author":"H Tang","year":"2020","unstructured":"Tang, H. et al. The noncoding and coding transcriptional landscape of the peripheral immune response in patients with COVID-19. Clini. Transl. Med. 10, e200 (2020).","journal-title":"Clini. Transl. Med."},{"key":"15898_CR37","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.ncrna.2020.11.005","volume":"5","author":"S Jafarinejad-Farsangi","year":"2020","unstructured":"Jafarinejad-Farsangi, S., Jazi, M. M., Rostamzadeh, F. & Hadizadeh, M. High affinity of host human micrornas to sars-cov-2 genome: An in silico analysis. Non-coding RNA Res. 5, 222\u2013231 (2020).","journal-title":"Non-coding RNA Res."},{"key":"15898_CR38","doi-asserted-by":"crossref","unstructured":"Bertolazzi, G., Cipollina, C., Benos, P.\u00a0V., Tumminello, M. & Coronnello, C. mir-1207-5p can contribute to dysregulation of inflammatory response in COVID-19 via targeting sars-cov-2 rna. Front. Cell. Infect. Microbiol. 673 (2020).","DOI":"10.3389\/fcimb.2020.586592"},{"key":"15898_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2020.e04658","volume":"6","author":"R Sardar","year":"2020","unstructured":"Sardar, R., Satish, D., Birla, S. & Gupta, D. Integrative analyses of SARS-CoV-2 genomes from different geographical locations reveal unique features potentially consequential to host-virus interaction, pathogenesis and clues for novel therapies. Heliyon 6, e04658 (2020).","journal-title":"Heliyon"},{"key":"15898_CR40","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1080\/15257770.2021.1950759","volume":"40","author":"A Sato","year":"2021","unstructured":"Sato, A., Ogino, Y., Tanuma, S.-I. & Uchiumi, F. Human microrna hsa-mir-15b-5p targets the rna template component of the rna-dependent rna polymerase structure in severe acute respiratory syndrome coronavirus 2. Nucleosides Nucleotides Nucleic Acids 40, 790\u2013797 (2021).","journal-title":"Nucleosides Nucleotides Nucleic Acids"},{"key":"15898_CR41","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1016\/j.cell.2018.01.029","volume":"172","author":"SA Lambert","year":"2018","unstructured":"Lambert, S. A. et al. The human transcription factors. Cell 172, 650\u2013665 (2018).","journal-title":"Cell"},{"key":"15898_CR42","doi-asserted-by":"crossref","unstructured":"Lam, M. T.\u00a0Y. et\u00a0al. Profiling transcription initiation in peripheral leukocytes reveals severity-associated cis-regulatory elements in critical COVID-19. BioRxiv (2021).","DOI":"10.1101\/2021.08.24.457187"},{"key":"15898_CR43","doi-asserted-by":"crossref","unstructured":"Freshour, S.\u00a0L. et\u00a0al. Integration of the drug-gene interaction database (DGIdb 4.0) with open crowdsource efforts. Nucleic Acids Res. 49, D1144\u2013D1151 (2021).","DOI":"10.1093\/nar\/gkaa1084"},{"key":"15898_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2020.110996","volume":"133","author":"Y Zhan","year":"2021","unstructured":"Zhan, Y. et al. Inhibiting RRM2 to enhance the anticancer activity of chemotherapy. Biomed. Pharmacother. 133, 110996 (2021).","journal-title":"Biomed. Pharmacother."},{"key":"15898_CR45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12967-020-02480-z","volume":"18","author":"L Perrin-Cocon","year":"2020","unstructured":"Perrin-Cocon, L. et al. The current landscape of coronavirus-host protein-protein interactions. J. Transl. Med. 18, 1\u201315 (2020).","journal-title":"J. Transl. Med."},{"key":"15898_CR46","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1038\/bjc.2013.817","volume":"110","author":"N Wang","year":"2014","unstructured":"Wang, N. et al. Increased expression of RRM2 by human papillomavirus E7 oncoprotein promotes angiogenesis in cervical cancer. Br. J. Cancer 110, 1034\u20131044 (2014).","journal-title":"Br. J. Cancer"},{"key":"15898_CR47","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1038\/onc.2015.109","volume":"35","author":"P Adamo","year":"2016","unstructured":"Adamo, P. & Ladomery, M. The oncogene ERG: A key factor in prostate cancer. Oncogene 35, 403\u2013414 (2016).","journal-title":"Oncogene"},{"key":"15898_CR48","doi-asserted-by":"publisher","DOI":"10.1016\/j.meegid.2020.104669","volume":"88","author":"A Afshari","year":"2021","unstructured":"Afshari, A., Janfeshan, S., Yaghobi, R., Roozbeh, J. & Azarpira, N. COVID-19 pathogenesis in prostatic cancer and TMPRSS2-ERG regulatory genetic pathway. Infect. Genet. Evol. 88, 104669 (2021).","journal-title":"Infect. Genet. Evol."},{"key":"15898_CR49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12920-020-00800-2","volume":"13","author":"B Yu","year":"2020","unstructured":"Yu, B. et al. TOP2A and CENPF are synergistic master regulators activated in cervical cancer. BMC Med. Genom. 13, 1\u201317 (2020).","journal-title":"BMC Med. Genom."},{"key":"15898_CR50","doi-asserted-by":"publisher","first-page":"2933","DOI":"10.7150\/jca.52187","volume":"12","author":"Y Huang","year":"2021","unstructured":"Huang, Y. et al. Centromere Protein F (CENPF) serves as a potential prognostic biomarker and target for human hepatocellular carcinoma. J. Cancer 12, 2933 (2021).","journal-title":"J. Cancer"},{"key":"15898_CR51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3892\/ol.2021.12909","volume":"22","author":"P-A Zou","year":"2021","unstructured":"Zou, P.-A., Yang, Z.-X., Wang, X. & Tao, Z.-W. Upregulation of CENPF is linked to aggressive features of osteosarcoma. Oncol. Lett. 22, 1\u20139 (2021).","journal-title":"Oncol. Lett."},{"key":"15898_CR52","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2020.109830","volume":"124","author":"Z Liu","year":"2020","unstructured":"Liu, Z. et al. Down-regulation of CIT can inhibit the growth of human bladder cancer cells. Biomed. Pharmacother. 124, 109830 (2020).","journal-title":"Biomed. Pharmacother."},{"key":"15898_CR53","doi-asserted-by":"crossref","unstructured":"Lu, W. et\u00a0al. High expression of citron kinase contributes to the development of esophageal squamous cell carcinoma. Front. Genet. 12 (2021).","DOI":"10.3389\/fgene.2021.628547"},{"key":"15898_CR54","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1038\/s41423-020-0485-9","volume":"17","author":"Y Ren","year":"2020","unstructured":"Ren, Y. et al. The ORF3a protein of SARS-CoV-2 induces apoptosis in cells. Cell. Mol. Immunol. 17, 881\u2013883 (2020).","journal-title":"Cell. Mol. Immunol."},{"key":"15898_CR55","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1016\/j.ijbiomac.2020.12.142","volume":"170","author":"M Bianchi","year":"2021","unstructured":"Bianchi, M., Borsetti, A., Ciccozzi, M. & Pascarella, S. SARS-Cov-2 ORF3a: Mutability and function. Int. J. Biol. Macromol. 170, 820\u2013826 (2021).","journal-title":"Int. J. Biol. Macromol."},{"key":"15898_CR56","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s10020-020-00216-9","volume":"26","author":"M Dattilo","year":"2020","unstructured":"Dattilo, M. The role of host defences in Covid 19 and treatments thereof. Mol. Med. 26, 1\u201315 (2020).","journal-title":"Mol. Med."},{"key":"15898_CR57","doi-asserted-by":"publisher","first-page":"6412","DOI":"10.3390\/ijms21176412","volume":"21","author":"N Batra","year":"2020","unstructured":"Batra, N., De Souza, C., Batra, J., Raetz, A. G. & Yu, A.-M. The HMOX1 pathway as a promising target for the treatment and prevention of SARS-CoV-2 of 2019 (COVID-19). Int. J. Mol. Sci. 21, 6412 (2020).","journal-title":"Int. J. Mol. Sci."},{"key":"15898_CR58","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41392-020-00451-w","volume":"6","author":"C Borgo","year":"2021","unstructured":"Borgo, C., D\u2019Amore, C., Sarno, S., Salvi, M. & Ruzzene, M. Protein kinase CK2: A potential therapeutic target for diverse human diseases. Signal Transduct. Target. Ther. 6, 1\u201320 (2021).","journal-title":"Signal Transduct. Target. Ther."},{"key":"15898_CR59","doi-asserted-by":"crossref","unstructured":"Stolfi, P., Manni, L., Soligo, M., Vergni, D. & Tieri, P. Designing a network proximity-based drug repurposing strategy for COVID-19. Front. Cell Dev. Biol. 8 (2020).","DOI":"10.3389\/fcell.2020.545089"},{"key":"15898_CR60","doi-asserted-by":"crossref","unstructured":"Pillaiyar, T. & Laufer, S. Kinases as potential therapeutic targets for anti-coronaviral therapy. J. Med. Chem. (2021).","DOI":"10.1021\/acs.jmedchem.1c00335"},{"key":"15898_CR61","doi-asserted-by":"publisher","first-page":"e01399","DOI":"10.1128\/JVI.01399-21","volume":"95","author":"Y-J Kim","year":"2021","unstructured":"Kim, Y.-J., Witwit, H., Cubitt, B. & de la Torre, J. C. Inhibitors of anti-apoptotic Bcl-2 family proteins exhibit potent and broad-spectrum anti-mammarenavirus activity via cell cycle arrest at G0\/G1 phase. J. Virol. 95, e01399-21 (2021).","journal-title":"J. Virol."},{"key":"15898_CR62","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11095-020-02851-7","volume":"37","author":"E Weisberg","year":"2020","unstructured":"Weisberg, E. et al. Repurposing of kinase inhibitors for treatment of COVID-19. Pharm. Res. 37, 1\u201329 (2020).","journal-title":"Pharm. Res."},{"key":"15898_CR63","doi-asserted-by":"publisher","DOI":"10.1016\/j.compbiomed.2020.104123","volume":"128","author":"P Krishnamoorthy","year":"2021","unstructured":"Krishnamoorthy, P., Raj, A. S., Roy, S., Kumar, N. S. & Kumar, H. Comparative transcriptome analysis of SARS-CoV, MERS-CoV, and SARS-CoV-2 to identify potential pathways for drug repurposing. Comput. Biol. Med. 128, 104123 (2021).","journal-title":"Comput. Biol. Med."},{"key":"15898_CR64","doi-asserted-by":"publisher","DOI":"10.1016\/j.imu.2021.100840","volume":"28","author":"MI Hasan","year":"2022","unstructured":"Hasan, M. I. et al. Systems biology and bioinformatics approach to identify blood based signatures molecules and drug targets of patient with COVID-19. Inform. Med. Unlocked 28, 100840 (2022).","journal-title":"Inform. Med. Unlocked"},{"key":"15898_CR65","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2020.109721","volume":"74","author":"R Poduri","year":"2020","unstructured":"Poduri, R., Joshi, G. & Jagadeesh, G. Drugs targeting various stages of the SARS-CoV-2 life cycle: Exploring promising drugs for the treatment of COVID-19. Cellul. Signal. 74, 109721 (2020).","journal-title":"Cellul. Signal."},{"key":"15898_CR66","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.cels.2020.10.003","volume":"12","author":"KA Overmyer","year":"2021","unstructured":"Overmyer, K. A. et al. Large-scale multi-omic analysis of COVID-19 severity. Cell Syst. 12, 23\u201340 (2021).","journal-title":"Cell Syst."},{"key":"15898_CR67","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2021.102151","volume":"24","author":"E Wyler","year":"2021","unstructured":"Wyler, E. et al. Transcriptomic profiling of SARS-CoV-2 infected human cell lines identifies HSP90 as target for COVID-19 therapy. Iscience 24, 102151 (2021).","journal-title":"Iscience"},{"key":"15898_CR68","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love, M. I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-Seq data with DESeq2. Genome Biol. 15, 1\u201321 (2014).","journal-title":"Genome Biol."},{"key":"15898_CR69","doi-asserted-by":"publisher","first-page":"D649","DOI":"10.1093\/nar\/gkx1132","volume":"46","author":"A Fabregat","year":"2018","unstructured":"Fabregat, A. et al. The reactome pathway knowledgebase. Nucleic Acids Res. 46, D649\u2013D655 (2018).","journal-title":"Nucleic Acids Res."},{"key":"15898_CR70","doi-asserted-by":"publisher","first-page":"W283","DOI":"10.1093\/nar\/gkv418","volume":"43","author":"M Hamed","year":"2015","unstructured":"Hamed, M., Spaniol, C., Nazarieh, M. & Helms, V. TFmiR: A web server for constructing and analyzing disease-specific transcription factor and miRNA co-regulatory networks. Nucleic Acids Res. 43, W283\u2013W288 (2015).","journal-title":"Nucleic Acids Res."},{"key":"15898_CR71","doi-asserted-by":"publisher","first-page":"D607","DOI":"10.1093\/nar\/gky1131","volume":"47","author":"D Szklarczyk","year":"2019","unstructured":"Szklarczyk, D. et al. STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets. Nucleic Acids Res. 47, D607\u2013D613 (2019).","journal-title":"Nucleic Acids Res."},{"key":"15898_CR72","doi-asserted-by":"publisher","first-page":"2498","DOI":"10.1101\/gr.1239303","volume":"13","author":"P Shannon","year":"2003","unstructured":"Shannon, P. et al. Cytoscape: A software environment for integrated models of biomolecular interaction networks. Genome Res. 13, 2498\u20132504 (2003).","journal-title":"Genome Res."},{"key":"15898_CR73","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1752-0509-8-S4-S11","volume":"8","author":"C-H Chin","year":"2014","unstructured":"Chin, C.-H. et al. cytoHubba: Identifying hub objects and sub-networks from complex interactome. BMC Syst. Biol. 8, 1\u20137 (2014).","journal-title":"BMC Syst. Biol."},{"key":"15898_CR74","doi-asserted-by":"crossref","unstructured":"Wishart, D.\u00a0S. et\u00a0al. Drugbank 5.0: A major update to the drugbank database for 2018. Nucleic Acids Res. 46, D1074\u2013D1082 (2018).","DOI":"10.1093\/nar\/gkx1037"},{"key":"15898_CR75","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.chembiol.2017.11.009","volume":"25","author":"J Tang","year":"2018","unstructured":"Tang, J. et al. Drug target commons: A community effort to build a consensus knowledge base for drug-target interactions. Cell Chem. Biol. 25, 224\u2013229 (2018).","journal-title":"Cell Chem. Biol."},{"key":"15898_CR76","unstructured":"Thorn, C.\u00a0F., Klein, T.\u00a0E. & Altman, R.\u00a0B. Pharmgkb. Pharmacogenomics 179\u2013191 (2005)."},{"key":"15898_CR77","doi-asserted-by":"publisher","first-page":"D945","DOI":"10.1093\/nar\/gkw1074","volume":"45","author":"A Gaulton","year":"2017","unstructured":"Gaulton, A. et al. The chembl database in 2017. Nucleic Acids Res. 45, D945\u2013D954 (2017).","journal-title":"Nucleic Acids Res."},{"key":"15898_CR78","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2105-12-77","volume":"12","author":"X Robin","year":"2011","unstructured":"Robin, X. et al. Proc: An open-source package for r and s+ to analyze and compare roc curves. BMC Bioinform. 12, 1\u20138 (2011).","journal-title":"BMC Bioinform."},{"key":"15898_CR79","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1093\/cvr\/cvab338","volume":"118","author":"C Gutmann","year":"2022","unstructured":"Gutmann, C. et al. Association of cardiometabolic micrornas with COVID-19 severity and mortality. Cardiovasc. Res. 118, 461\u2013474 (2022).","journal-title":"Cardiovasc. Res."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-15898-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-15898-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-15898-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,25]],"date-time":"2022-11-25T04:13:04Z","timestamp":1669349584000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-15898-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,13]]},"references-count":79,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["15898"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-15898-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,13]]},"assertion":[{"value":"11 February 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 July 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"11934"}}